Questions and Panel Discussion - Post-approval CMC and Manufacturing - REdI 2020

  Рет қаралды 1,995

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
FDA Drug Manufacturing Inspections - REdI 2020
52:33
U.S. Food and Drug Administration
Рет қаралды 9 М.
Lifecycle Changes to Chemistry, Manufacture, and Controls in NDAs - REdI 2020
34:37
U.S. Food and Drug Administration
Рет қаралды 3,8 М.
Как Ходили родители в ШКОЛУ!
0:49
Family Box
Рет қаралды 2,3 МЛН
-5+3은 뭔가요? 📚 #shorts
0:19
5 분 Tricks
Рет қаралды 13 МЛН
Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020
28:11
Common CMC (Quality) Issues and How to Avoid Them Part I (12of16) Generic Drugs Forum
57:58
U.S. Food and Drug Administration
Рет қаралды 7 М.
CMC - NDA requirements and Common Pitfalls of BLAs (14of15) REdI - May 29-30, 2019
1:10:48
U.S. Food and Drug Administration
Рет қаралды 10 М.
ICH M7(R1) - Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment
20:33
U.S. Food and Drug Administration
Рет қаралды 7 М.
Chemistry and Manufacturing Requirements for Early Clinical Development: What’s in there? Prove it.
1:02:19
Introduction to the Drug Master File (DMF) Review Process
24:28
U.S. Food and Drug Administration
Рет қаралды 10 М.
CMC Considerations for CAR T Cell Product Development
29:42
U.S. Food and Drug Administration
Рет қаралды 12 М.
CDER BIMO: Electronic Submission Requirements for New Drug and Biologic Licensing Applications
17:02
MEDIA CALL: Front of Package Nutrition Labels - 1/14/2025
19:15
U.S. Food and Drug Administration
Рет қаралды 749
Как Ходили родители в ШКОЛУ!
0:49
Family Box
Рет қаралды 2,3 МЛН